While CD43 is recognized as a surface marker predominantly found in T lymphocytes [81], it has also been detected in various malignant cells, including those associated with CLL, as well as in myeloid malignancies [82,83,84]. This evidence concerns the gene SPN and B-cell chronic lymphocytic leukemia.